Beyond tirzepatide, other incretin-based therapies have shown promise, such as retatrutide, a novel triple-hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, with early-phase trials demonstrating profound effects on weight reduction [36]
Ozempic is a brand-name injectable medication containing semaglutide, which is a GLP-1 receptor agonist
At the Center for Nutrition, we use the power of synergy between our most proven nutritional protocols along with new synergistic medication combinations
Helpful strategies include: Eating smaller meals Eating slowly and stopping when comfortably full Including protein with every meal Avoiding greasy or very rich foods Staying well hydrated Taking the medication exactly as prescribed Maintaining an active lifestyle is essential when taking GLP-1 medications, as regular exercise, including strength training, helps preserve muscle mass during weight loss
If the label says 10 mg/mL tirzepatide, then 50 units still delivers 5 mg of tirzepatide regardless of what other compounds are in the solution